
- Pharmaceutical Technology-02-02-2018
- Volume 42
- Issue 2
Establishing Correlation Between Aerosol and Surface Microbial Populations
The following study describes a methodology to establish, control, and characterize an aerosolized bioburden within a test chamber and determine the settling rate of the bioburden.
Pharmaceutical and nutritional package integrity is often studied by incidental contamination, via immersion or aerosol microbiological challenge tests. Aerosol tests rely upon microorganisms settling from the atmosphere onto critical surfaces. Maintenance of a contaminated atmosphere is necessary to create the conditions that will cause a constant settling rate of the test microorganisms. Both parameters--maintenance of bioburden and duration of exposure--have to be monitored and controlled. It is important to understand the limitations of aerosol tests where the microbial contamination conditions are not maintained over the duration of the test. The following study describes a methodology to establish, control, and characterize an aerosolized bioburden within a test chamber and determine the settling rate of the bioburden. The intention of this paper is to stimulate the necessary discussion for the establishment of the standard criteria for all aerosol tests to generate comparable and reproducible data.
Peer-Reviewed
Submitted: Aug. 25, 2017
Accepted: Dec. 8, 2017
About the Authors
F. Andreas Toba* is vice president, Intact Pharma Operations, atoba@medinstill.com; David A. Miller is manager, Device Performance Engineering; Debashis Sahoo is executive vice-president, Regulators & Key Customers; and Daniel Py is chairman and CEO-all at MedInstill Development. Bryan R. Campbell is a Doctor of Osteopathic Medicine at Touro University Nevada; and James P. Agalloco is president, Agalloco & Associates, and a member of the Pharmaceutical Technology editorial advisory board.
*To whom all correspondence should be addressed.
Article Details
Pharmaceutical Technology
Vol. 42, No. 2
February 2018
Page: 44–51
Citation
When referring to this article, please cite as F.A. Toba et. al, “Establishing Correlation Between Aerosol and Surface Microbial Populations,” Pharmaceutical Technology 42 (2) 2018.
Articles in this issue
almost 8 years ago
Designing a Single-Use Biopharmaceutical Processalmost 8 years ago
Material Traceability in Continuous Pharmaceutical Tablet Manufacturingalmost 8 years ago
Analyzing Content Uniformityalmost 8 years ago
Impurity Testingalmost 8 years ago
Tabletop Peristaltic Liquid-Filling Machinealmost 8 years ago
Safety Light Curtain Feature on Tumble Blendersalmost 8 years ago
Aqueous Sugar Film Coating Systemalmost 8 years ago
USB Data Logger for Temperature-Sensitive Productsalmost 8 years ago
Navigating Data Integrity in the Modern LabNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





